Subscribe to Search results

Dr Robert Perry gave evidence that PFC pool sizes from 1978/79 to 1983/84 increased.

Published on:

Annual payments made by the Skipton Fund were extended to people who had received Stage 1 payments as well as Stage 2.

Published on:

Lord Hunt asked about the scope for "doing more" for people with haemophilia infected with Hepatitis C and requested an outline costing of a hardship fund. The advice provided said that such a fund would be unlikely to be acceptable and that there would be a continuing demand for parity with the HIV scheme.

Published on:

Dr Paul Giangrande, director of the Oxford Haemophilia Centre, wrote to the Department of Health, expressing the view that "some form of payment should be made to patients who have simply tested positive for the HCV antibody, even if they subsequently cleared this and did not have abnormal liver function tests"; and that it was "grossly unfair" that people coinfected "should not receive additional compensation".

Published on:

A meeting was held to discuss ex gratia payments to patients who were infected with Hepatitis C as a result of NHS treatment with blood or blood products. It was attended by Andrew MacLeod and Bob Stock from the Scottish Executive, and Richard Gutowski and David Reay from the Department of Health.

Published on:

A teleconference was arranged by the Department of Health to discuss the inconsistency in the reviewing of natural clearers by clinicians. Professor Christine Lee spoke about her concerns. Clear instructions were needed to eliminate the disparity.

Published on:

A letter from Karin Pappenheim, chief executive of the Haemophilia Society, to Richard Gutowski, Head of Blood Policy Division, expressed concerns regarding the Hepatitis ex gratia scheme.

Published on:

A letter from Professor Christine Lee to William Connon of the Blood Policy Group stated that 15-20% of individuals who were infected with Hepatitis C cleared the virus naturally.

Published on:

An email exchange took place between Peter Stevens, Richard Gutowski and others regarding the approach to be taken to applicants to the Skipton Fund who had cleared the Hepatitis C virus spontaneously.

Published on:

An email exchange took place between Richard Gutowski, Peter Stevens and others regarding the position of spontaneous clearers. Richard Gutowski stated "As far as spontaneous clearers are concerned...our position remains unchanged. They do not come within the scope of the Scheme."

Published on:

The Scottish Expert Group on Financial and Other Support was set up to look at the pros and cons of a system of financial and other support for those harmed by health service treatment where the NHS was not at fault.

Published on:

A disagreement began between the UK Government and Scottish Executive as to whether making payments to relieve financial hardship out of health care treatment was something that the Scottish Executive had a right to legislate on. Malcolm Chisholm said that the advice he had was that this was a devolved matter but he was not sure this was right.

Published on:

The Secretary of State wrote to Malcolm Chisholm informing him that an ex gratia payment scheme for people in Scotland who had been infected with Hepatitis C as a result of treatment with NHS blood/blood products would be accepted as falling within devolved competence.

Published on:

A document relating to spontaneous clearance of Hepatitis C suggested press lines to be adopted, including "Ministers have made it clear from the outset that the scheme would only make payments to patients who had experienced lasting physiological harm as a result of their infection."

Published on:

Further nominees for expert groups put forward

Published on:

"The surveillance of transfusion-associated viral hepatitis" was published in the Journal of the American Medical Association. The article supported Dr Allen's striking "ten times" finding.

Published on:

In his book "The Gift Relationship", Professor Richard Titmuss commented on the additional risk created by paid donations mixed in commercial pools in the US.

Published on:

Dr Craske linked the risks of commercial concentrates from large pools with domestic production.

Published on:

A letter from Dr Garrott Allen to Dr Maycock emphasised the risks associated with commercial blood in a mixed combination to bring up an astounding attack rate from one that was relatively unnoticed.

Published on:

Dr Maycock knew the risks associated with commercial blood in a mixed combination to bring up an astounding attack rate; possibly Dr Owen knew of this too.

Published on: